Cuproptosis-Related Gene – SLC31A1, FDX1 and ATP7B – Polymorphisms are Associated with Risk of Lung Cancer

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Cao M, Chen W. Epidemiology of lung cancer in China. Thorac Cancer. 2019;10(1):3–7.
   PubMed Web of Science ®Google Scholar
• Donington JS, Kim YT, Tong B, et al. Progress in the management of early-stage non-small cell lung cancer in 2017. J Thorac Oncol. 2018;13(6):767–778.
   PubMed Web of Science ®Google Scholar
• Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomark Prev. 2019;28(10):1563–1579.
   PubMed Web of Science ®Google Scholar
• Akhtar N, Bansal JG. Risk factors of lung cancer in nonsmoker. Curr Probl Cancer. 2017;41(5):328–339.
   PubMed Web of Science ®Google Scholar
• Cannon-Albright LA, Carr SR, Akerley W. Population-based relative risks for lung cancer based on complete family history of lung cancer. J Thorac Oncol. 2019;14(7):1184–1191.
   PubMed Web of Science ®Google Scholar
• McKay JD, Hung RJ, Han Y, et al. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet. 2017;49(7):1126–1132.
   PubMed Web of Science ®Google Scholar
• Maya I, Basel-Salmon L, Singer A, Sagi-Dain L. High-frequency low-penetrance copy-number variant classification: should we revise the existing guidelines? Genet Med. 2020;22(7):1276–1277.
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 2022:32(5):417–418.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang Q. Association between serum copper levels and lung cancer risk: a meta-analysis. J Int Med Res. 2018;46(12):4863–4873.
   PubMed Web of Science ®Google Scholar
• Oliveri V. Selective targeting of cancer cells by copper ionophores: an overview. Front Mol Biosci. 2022;9:841814.
   PubMed Web of Science ®Google Scholar
• Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254–1261.
   PubMed Web of Science ®Google Scholar
• Kilari D, Guancial E, Kim ES. Role of copper transporters in platinum resistance. World J Clin Oncol. 2016;7(1):106–113.
   PubMedGoogle Scholar
• Pantoom S, Pomorski A, Huth K, et al. Direct interaction of ATP7B and LC3B proteins suggests a cooperative role of copper transportation and autophagy. Cells. 2021;10:11.
   Web of Science ®Google Scholar
• Collins CJ, Yi F, Dayuha R, et al. Direct measurement of ATP7B peptides is highly effective in the diagnosis of Wilson disease. Gastroenterology. 2021;160(7):2367–2382.e2361.
   PubMed Web of Science ®Google Scholar
• Fujita K, Motoyama S, Sato Y, et al. Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy. Med Oncol. 2021;38(1):6.
   PubMed Web of Science ®Google Scholar
• Sun C, Zhang Z, Qie J, et al. Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation. Oncotarget. 2018;9(35):23860–23877.
   PubMedGoogle Scholar
• Xu X, Ren H, Zhou B, et al. Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients. Lung Cancer. 2012;77(2):438–442.
   PubMed Web of Science ®Google Scholar
• Niu D, Gao Y, Xie L, et al. Genetic polymorphisms in TNFSF13 and FDX1 are associated with IgA nephropathy in the Han Chinese population. Hum Immunol. 2015;76(11):831–835.
   PubMed Web of Science ®Google Scholar
• Li YQ, Zhang XY, Chen J, Yin JY, Li XP. ATP7B rs9535826 is associated with gastrointestinal toxicity of platinum-based chemotherapy in nonsmall cell lung cancer patients. J Cancer Res Ther. 2018;14(4):881–886.
   PubMed Web of Science ®Google Scholar
• Li XP, Yin JY, Wang Y, et al. The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients. Tumour Biol. 2014;35(8):8259–8265.
   PubMedGoogle Scholar
• Shanbhag VC, Gudekar N, Jasmer K, Papageorgiou C, Singh K, Petris MJ. Copper metabolism as a unique vulnerability in cancer. Biochim Biophys Acta Mol Cell Res. 2021;1868(2):118893.
   PubMed Web of Science ®Google Scholar
• Wee NK, Weinstein DC, Fraser ST, Assinder SJ. The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease. Int J Biochem Cell Biol. 2013;45(5):960–963.
   PubMed Web of Science ®Google Scholar
• Ishida S, McCormick F, Smith-McCune K, Hanahan D. Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell. 2010;17(6):574–583.
   PubMed Web of Science ®Google Scholar
• Barresi V, Trovato-Salinaro A, Spampinato G, et al. Transcriptome analysis of copper homeostasis genes reveals coordinated upregulation of SLC31A1, SCO1, and COX11 in colorectal cancer. FEBS Open Bio. 2016;6(8):794–806.
   PubMed Web of Science ®Google Scholar
• Safi R, Nelson ER, Chitneni SK, et al. Copper signaling axis as a target for prostate cancer therapeutics. Cancer Res. 2014;74(20):5819–5831.
   PubMed Web of Science ®Google Scholar
• Wachsmann J, Peng F. Molecular imaging and therapy targeting copper metabolism in hepatocellular carcinoma. World J Gastroenterol. 2016;22(1):221–231.
   PubMed Web of Science ®Google Scholar
• Yu Z, Zhou R, Zhao Y, et al. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Cell Prolif. 2019;52(2):e12568.
   PubMed Web of Science ®Google Scholar
• Wu G, Peng H, Tang M, et al. ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression. EBioMedicine. 2021;71:103558.
   PubMed Web of Science ®Google Scholar
• Wang L, Sun C, Li X, et al. A pharmacogenetics study of platinum-based chemotherapy in lung cancer: ABCG2 polymorphism and its genetic interaction with SLC31A1 are associated with response and survival. J Cancer. 2021;12(5):1270–1283.
   PubMed Web of Science ®Google Scholar
• Sheftel AD, Stehling O, Pierik AJ, et al. Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis. Proc Natl Acad Sci U S A. 2010;107(26):11775–11780.
   PubMed Web of Science ®Google Scholar
• Shi Y, Ghosh M, Kovtunovych G, Crooks DR, Rouault TA. Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis. Biochim Biophys Acta. 2012;1823(2):484–492.
   PubMed Web of Science ®Google Scholar
• Cai K, Tonelli M, Frederick RO, Markley JL. Human mitochondrial Ferredoxin 1 (FDX1) and Ferredoxin 2 (FDX2) both bind cysteine desulfurase and donate electrons for iron-sulfur cluster biosynthesis. Biochemistry. 2017;56(3):487–499.
   PubMed Web of Science ®Google Scholar
• Tsvetkov P, Detappe A, Cai K, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15(7):681–689.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ma Y, Guo X, et al. FDX1 can impact the prognosis and mediate the metabolism of lung adenocarcinoma. Front Pharmacol. 2021;12:749134.
   PubMed Web of Science ®Google Scholar
• Polishchuk EV, Concilli M, Iacobacci S, et al. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev Cell. 2014;29(6):686–700.
   PubMed Web of Science ®Google Scholar
• Bartee MY, Lutsenko S. Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level. Biometals. 2007;20(3–4):627–637.
   PubMed Web of Science ®Google Scholar
• Yang T, Chen M, Chen T, Thakur A. Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer. Oncol Lett. 2015;10(4):2584–2590.
   PubMed Web of Science ®Google Scholar
• Li YQ, Chen J, Yin JY, Liu ZQ, Li XP. Gene expression and single nucleotide polymorphism of ATP7B are associated with platinum-based chemotherapy response in non-small cell lung cancer patients. J Cancer. 2018;9(19):3532–3539.
   PubMed Web of Science ®Google Scholar
• Fukushima-Uesaka H, Saito Y, Maekawa K, et al. Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients. Drug Metab Pharmacokinet. 2009;24(6):565–574.
   PubMed Web of Science ®Google Scholar
• Schmid SC, Schuster T, Horn T, Gschwend J, Treiber U, Weirich G. Utility of ATP7B in prediction of response to platinum-based chemotherapy in urothelial bladder cancer. Anticancer Res. 2013;33(9):3731–3737.
   PubMed Web of Science ®Google Scholar
• Ji Y, Yang Y, Yin Z. Polymorphisms in lncRNA CCAT1 on the susceptibility of lung cancer in a Chinese northeast population: a case-control study. Cancer Med. 2022. doi:10.1002/cam4.4902.
   Web of Science ®Google Scholar
• Liu W, Zhang Y, Huang F, et al. The polymorphism and expression of EGFL7 and miR-126 are associated with NSCLC susceptibility. Front Oncol. 2022;12:772405.
   PubMed Web of Science ®Google Scholar
• Yu Y, Mao L, Cheng Z, et al. A novel regQTL-SNP and the risk of lung cancer: a multi-dimensional study. Arch Toxicol. 2021;95(12):3815–3827.
   PubMed Web of Science ®Google Scholar